What is the share price of India Glycols Ltd (INDIAGLYCO) today?
The share price of INDIAGLYCO as on 24th July 2026 is ₹1157.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on India Glycols Ltd (INDIAGLYCO) share?
The past returns of India Glycols Ltd (INDIAGLYCO) share are- Past 1 week: 0.24%
- Past 1 month: 23.88%
- Past 3 months: 20.20%
- Past 6 months: 43.17%
- Past 1 year: 31.90%
- Past 3 years: 280.60%
- Past 5 years: 231.24%
What are the peers or stocks similar to India Glycols Ltd (INDIAGLYCO)?
The peers or stocks similar to India Glycols Ltd (INDIAGLYCO) include:What is the dividend yield % of India Glycols Ltd (INDIAGLYCO) share?
The current dividend yield of India Glycols Ltd (INDIAGLYCO) is 0.60.What is the market cap of India Glycols Ltd (INDIAGLYCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of India Glycols Ltd (INDIAGLYCO) is ₹7760.36 Cr as of 24th July 2026.What is the 52 week high and low of India Glycols Ltd (INDIAGLYCO) share?
The 52-week high of India Glycols Ltd (INDIAGLYCO) is ₹1222 and the 52-week low is ₹792.50.What is the PE and PB ratio of India Glycols Ltd (INDIAGLYCO) stock?
The P/E (price-to-earnings) ratio of India Glycols Ltd (INDIAGLYCO) is 26.51. The P/B (price-to-book) ratio is 3.44.Which sector does India Glycols Ltd (INDIAGLYCO) belong to?
India Glycols Ltd (INDIAGLYCO) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy India Glycols Ltd (INDIAGLYCO) shares?
You can directly buy India Glycols Ltd (INDIAGLYCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
India Glycols Ltd
INDIAGLYCO Share Price
NSE₹1,157.801.32% (-15.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
INDIAGLYCO Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDIAGLYCO Performance & Key Metrics
INDIAGLYCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 26.51 | 3.44 | 0.60% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 23.95 | 3.15 | 1.41% |
INDIAGLYCO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDIAGLYCO Company Profile
India Glycols Limited is a company engaged in the manufacturing of technology-based bulk, specialty and performance chemicals, natural gums, spirits, industrial gases, sugar and nutraceuticals.
SOLARINDS
PE Ratio
99.76
99.76
1Y Return
25.37%
25.37%
Buy Reco %
84.62
84.62
LINDEINDIA
PE Ratio
104.57
104.57
1Y Return
1.90%
1.90%
Buy Reco %
0.00
0.00
PE Ratio
53.02
53.02
1Y Return
53.91%
53.91%
Buy Reco %
0.00
0.00
SUMICHEM
PE Ratio
47.84
47.84
1Y Return
11.93%
11.93%
Buy Reco %
88.89
88.89
DEEPAKNTR
PE Ratio
40.87
40.87
1Y Return
14.21%
14.21%
Buy Reco %
47.06
47.06
INDIAGLYCO Sentiment Analysis
INDIAGLYCO Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
INDIAGLYCO Stock Summary · May 2026
The call conveyed broad top‑line and margin improvement, with FY26 net revenues of INR 4,211 crore (up 11.8% YoY) and EBITDA of INR 654 crore (up 24.5%), driving a reported EBITDA margin expansion to 15.5%. Management struck a constructive, execution‑focused tone, emphasizing premiumization in potable spirits through SKU, distribution and brand expansion, accelerated ethanol/bio‑fuels momentum aided by policy tailwinds, and a deliberate shift in chemicals toward higher‑value products while pruning low‑margin businesses. They acknowledged tensions: chemicals revenue declined even as margins improved, a routine plant shutdown temporarily constrained EO‑based sales and JV volumes, and a diversified biopharma unit showed a Q4 rebound but ongoing margin pressure with no material EBITDA pickup expected this year. Capital allocation and balance‑sheet repair were highlighted — roughly INR 800 crore of prepayments funded by equity and cash flow reduced leverage but left net debt only modestly lower amid working‑capital shifts — and management reiterated near‑term expectations for declining interest costs (to about INR 25 crore per quarter), a hoped demerger order soon, and a planned 2028–29 JV stake sale to eliminate Chemicals’ term debt.
INDIAGLYCO Stock Growth Drivers
INDIAGLYCO Stock Growth Drivers
7Strong FY26 Financial Performance and Margin Expansion
The company delivered a marked improvement in full‑year FY26 financials with gross revenues of INR
Bio‑Fuels and Ethanol Competitiveness with Policy Upside
The bio‑fuels business delivered an excellent year and quarter, with FY26 revenue of INR 1,470
INDIAGLYCO Stock Challenges
INDIAGLYCO Stock Challenges
6Input-cost inflation and feedstock supply disruptions
The company faces sustained input-cost pressure and intermittent feedstock shortages driven by geopolitical events and
Scheduled plant shutdowns and ethylene oxide (EO) supply interruptions
Recurring, scheduled shutdowns for catalyst changeovers are materially disrupting continuous production and downstream sales. Management
INDIAGLYCO Forecast
INDIAGLYCO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
INDIAGLYCO
INDIAGLYCO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
INDIAGLYCO Income Statement
INDIAGLYCO Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 913.50 | 935.83 | 982.16 | 976.36 | 994.50 | 876.19 | 1,060.48 | 1,105.93 | 1,106.40 | 989.95 | ||||||||||
Operating & Other expenses | 801.96 | 821.56 | 843.08 | 845.42 | 851.54 | 717.28 | 890.82 | 934.56 | 927.76 | 809.85 | ||||||||||
EBITDA | 111.54 | 114.27 | 139.08 | 130.94 | 142.96 | 158.91 | 169.66 | 171.37 | 178.64 | 180.10 | ||||||||||
| Depreciation/Amortization | 26.24 | 26.04 | 27.57 | 27.57 | 27.47 | 32.59 | 34.45 | 38.48 | 41.22 | 41.23 | ||||||||||
| PBIT | 85.30 | 88.23 | 111.51 | 103.37 | 115.49 | 126.32 | 135.21 | 132.89 | 137.42 | 138.87 | ||||||||||
| Interest & Other Items | 31.41 | 32.63 | 35.86 | 39.91 | 44.07 | 44.53 | 44.68 | 49.28 | 46.81 | 26.41 | ||||||||||
| PBT | 53.89 | 55.60 | 75.65 | 63.46 | 71.42 | 81.79 | 90.53 | 83.61 | 90.61 | 112.46 | ||||||||||
| Taxes & Other Items | 12.26 | 13.39 | 15.27 | 13.75 | 14.61 | 17.77 | 17.28 | 18.55 | 23.04 | 25.58 | ||||||||||
| Net Income | 41.63 | 42.21 | 60.38 | 49.71 | 56.81 | 64.02 | 73.25 | 65.06 | 67.57 | 86.88 | ||||||||||
| EPS | 6.73 | 6.82 | 9.75 | 8.03 | 9.18 | 10.34 | 11.83 | 10.51 | 10.79 | 13.64 |
INDIAGLYCO Company Updates
INDIAGLYCO Stock Peers
INDIAGLYCO Past Performance & Peer Comparison
INDIAGLYCO Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| India Glycols Ltd | 26.51 | 3.44 | 0.60% |
| Solar Industries India Ltd | 99.76 | 25.55 | 0.06% |
| Linde India Ltd | 104.57 | 13.45 | 0.18% |
| Himadri Speciality Chemical Ltd | 53.02 | 8.37 | 0.10% |
INDIAGLYCO Stock Price Comparison
Compare INDIAGLYCO with any stock or ETFCompare INDIAGLYCO with any stock or ETF
INDIAGLYCO
INDIAGLYCO Holdings
INDIAGLYCO Shareholdings
INDIAGLYCO Promoter Holdings Trend
INDIAGLYCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDIAGLYCO Institutional Holdings Trend
INDIAGLYCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding History
INDIAGLYCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDIAGLYCO
Mutual Funds Invested in INDIAGLYCO
No mutual funds holding trends are available
Top 5 Mutual Funds holding India Glycols Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1058% | Percentage of the fund’s portfolio invested in the stock 0.48% | Change in the portfolio weight of the stock over the last 3 months 0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/115 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0782% | Percentage of the fund’s portfolio invested in the stock 0.25% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 53/255 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 190/755 (+6) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDIAGLYCO stock
smallcases containing INDIAGLYCO stock
Looks like this stock is not in any smallcase yet.
INDIAGLYCO Events
INDIAGLYCO Events
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.60%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.98 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.60%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.98 every year
INDIAGLYCO Upcoming Dividends
INDIAGLYCO Upcoming Dividends
No upcoming dividends are available
INDIAGLYCO Past Dividends
INDIAGLYCO Past Dividends
Cash Dividend
Ex DateEx DateMar 23, 2026
Interim
Interim | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Mar 23, 2026
Cash Dividend
Ex DateEx DateSep 23, 2025
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Sep 23, 2025
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹8.00
Dividend/Share
₹8.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateSep 5, 2023
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Sep 5, 2023
Cash Dividend
Ex DateEx DateAug 29, 2022
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Aug 29, 2022
INDIAGLYCO Stock News & Opinions
INDIAGLYCO Stock News & Opinions
Articles & Videos
Corporate
Corporate
India Glycols to convene AGMIndia Glycols announced that the Annual General Meeting(AGM) of the company will be held on 19 August 2026.
3 days agoCapital Market - Live
Earnings
Earnings
India Glycols consolidated net profit rises 35.71% in the March 2026 quarterNet profit of India Glycols rose 35.71% to Rs 86.88 crore in the quarter ended March 2026 as against Rs 64.02 crore during the previous quarter ended March 2025. Sales rose 13.11% to Rs 976.35 crore in the quarter ended March 2026 as against Rs 863.22 crore during the previous quarter ended March 2025. For the full year,net profit rose 26.78% to Rs 292.76 crore in the year ended March 2026 as against Rs 230.92 crore during the previous year ended March 2025. Sales rose 11.76% to Rs 4211.41 crore in the year ended March 2026 as against Rs 3768.26 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales976.35863.22 13 4211.413768.26 12 OPM %17.0516.91 -15.4213.56 - PBDT153.69114.38 34 533.42407.52 31 PBT112.4681.79 37 378.04292.32 29 NP86.8864.02 36 292.76230.92 27 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
India Glycols to discuss resultsIndia Glycols will hold a meeting of the Board of Directors of the Company on 14 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Board of India Glycols recommends interim dividendIndia Glycols announced that the Board of Directors of the Company at its meeting held on 17 March 2026, inter alia, have recommended the interim dividend of Rs 7.5 per equity Share (i.e. 150%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
India Glycols announces board meeting dateIndia Glycols will hold a meeting of the Board of Directors of the Company on 17 March 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
India Glycols receives ratings action from CAREIndia Glycols announced that CARE has assigned the rating CARE A- ; CARE A2+ for bank facilities of the company while continuing to place the rating on watch with developing implications. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
India Glycols to hold EGMIndia Glycols announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 24 March 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
India Glycols consolidated net profit rises 18.94% in the December 2025 quarterNet profit of India Glycols rose 18.94% to Rs 67.57 crore in the quarter ended December 2025 as against Rs 56.81 crore during the previous quarter ended December 2024. Sales rose 13.04% to Rs 1102.40 crore in the quarter ended December 2025 as against Rs 975.20 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1102.40975.20 13 OPM %15.9212.68 - PBDT132.6698.89 34 PBT91.4471.42 28 NP67.5756.81 19 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
India Glycols to table resultsIndia Glycols will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Spotlight
Spotlight
India Glycols hits record high after Q2 PAT rises 31% YoY to Rs 65 crProfit before tax (PBT) rose 31.8% YoY to Rs 83.61 crore in Q2 FY26. Total expenses rose 11.79% to Rs 2342.52 crore in Q2 FY26 compared with Rs 2095.41 crore posted in corresponding quarter last year. Cost of material consumed stood at Rs 660.85 crore (up 13.11% YoY), employee benefit expenses was at Rs 32.11 crore (up 6.04% YoY), finance cost stood at Rs 49.28 crore (up 23.48% YoY) during the quarter. In Q2 FY26, revenue from Bio Fuel segment stood at Rs 422.81 crore, up 62.89% YoY, revenue from potable spirits jumped 14.04% YoY to Rs 1,657.82 crore,. However, the Ennature Biopharma segment reported a decline of 28.73% YoY to Rs 43.44 crore and revenue from bio-based specialties and performance chemicals business dropped 21.95% YoY to Rs 288.33 crore. India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB). The scrip touched an all-time high at Rs 1,134.60 in intraday today.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.6%, vs industry avg of 14.01%
Over the last 5 years, market share increased from 2.97% to 3.06%
Over the last 5 years, net income has grown at a yearly rate of 17.34%, vs industry avg of 9.98%